Header Logo

Connection

Alan Landay to Sulfoxides

Back to Details
This is a "connection" page, showing publications Alan Landay has written about Sulfoxides.
Alan Landay
Connection Strength
0.034
Sulfoxides
  1. A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus. AIDS. 2016 Mar 27; 30(6):869-78.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.